Correlation Between Valbiotis SAS and OSE Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valbiotis SAS and OSE Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valbiotis SAS and OSE Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valbiotis SAS and OSE Pharma SA, you can compare the effects of market volatilities on Valbiotis SAS and OSE Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valbiotis SAS with a short position of OSE Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valbiotis SAS and OSE Pharma.

Diversification Opportunities for Valbiotis SAS and OSE Pharma

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Valbiotis and OSE is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Valbiotis SAS and OSE Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OSE Pharma SA and Valbiotis SAS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valbiotis SAS are associated (or correlated) with OSE Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OSE Pharma SA has no effect on the direction of Valbiotis SAS i.e., Valbiotis SAS and OSE Pharma go up and down completely randomly.

Pair Corralation between Valbiotis SAS and OSE Pharma

Assuming the 90 days trading horizon Valbiotis SAS is expected to under-perform the OSE Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Valbiotis SAS is 1.09 times less risky than OSE Pharma. The stock trades about -0.02 of its potential returns per unit of risk. The OSE Pharma SA is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  641.00  in OSE Pharma SA on October 26, 2024 and sell it today you would lose (4.00) from holding OSE Pharma SA or give up 0.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Valbiotis SAS  vs.  OSE Pharma SA

 Performance 
       Timeline  
Valbiotis SAS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Valbiotis SAS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Valbiotis SAS may actually be approaching a critical reversion point that can send shares even higher in February 2025.
OSE Pharma SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OSE Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Valbiotis SAS and OSE Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valbiotis SAS and OSE Pharma

The main advantage of trading using opposite Valbiotis SAS and OSE Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valbiotis SAS position performs unexpectedly, OSE Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OSE Pharma will offset losses from the drop in OSE Pharma's long position.
The idea behind Valbiotis SAS and OSE Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years